ALIGNMT AI Inc.

Based in the US, ALIGNMT AI Inc. operates as a provider of healthcare artificial intelligence compliance and risk management solutions. Founded in 2023 and headquartered in New York, US, ALIGNMT AI Inc. focuses on healthcare AI compliance solutions.

The company has secured a SEED funding round of USD 6. 5 mn led by AIX Ventures, with participation from Alumni Ventures Group and Sancus Ventures. The funding will support their growth strategy, targeting expansion in healthcare AI compliance infrastructure and monitoring systems deployment. The company has completed a total of 1 deal to date, with the most recent deal occurring on August 28, 2025.

ALIGNMT AI specializes in providing a comprehensive suite of solutions for compliance and risk management in healthcare artificial intelligence. Their offerings include an AI Governance Platform and AI Risk Assessment tools that streamline adherence to ISO, NIST, and ONC standards. The solutions facilitate the oversight of data management and AI systems, allowing healthcare organizations to manage the complexities of AI deployment effectively. Clients benefit from continuous monitoring of AI performance, risk analysis, and transparency through AI report cards.

ALIGNMT AI's products are utilized in 57 countries, primarily serving healthcare providers and institutions seeking responsible and ethical AI enhancement. ALIGNMT AI generates revenue through a subscription-based model for its AI governance and risk management platforms, primarily serving B2B clients in the healthcare sector. Clients subscribe to access tools that automate compliance and facilitate quality reporting. The company’s main offerings, which include risk assessment and continuous monitoring solutions, are structured to provide ongoing support and updates in line with industry standards.

This approach fosters long-term partnerships with clients, enhancing the quality and trustworthiness of AI applications in the healthcare industry. Following the SEED funding round on August 28, 2025, ALIGNMT AI Inc. plans to leverage the USD 6. 5 mn raised to develop their artificial intelligence monitoring systems and expand their healthcare compliance infrastructure.

The company is also focusing on setting up an equity risk detection platform to further enhance their service offerings. These initiatives aim to position ALIGNMT AI for growth in new markets and regions, reinforcing their commitment to supporting responsible AI deployment in healthcare.